| |
| |
|
| Insider
Information: |
Rombotis Spiro |
| Relationship: |
President and CEO, Dir... |
| City: |
Short Hills |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
68,658 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,777 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
68,658 |
|
|
| Total
Value |
$26,777 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cyclacel Pharmaceuticals Inc |
CYCC |
President and CEO, Dir... |
2023-12-21 |
68,658 |
2006-03-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYCC |
Cyclacel Pharmaceuticals ... |
President and CEO |
• • – |
2023-12-21 |
4 |
B |
$3.32 |
$20,122 |
D/D |
6,070 |
68,658 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President and CEO |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
57,600 |
62,588 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & CEO |
• • – |
2014-12-06 |
5 |
D |
$2.99 |
$11,634 |
D/D |
(3,891) |
237,525 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2013-05-21 |
4 |
B |
$3.00 |
$300,000 |
D/D |
100,000 |
241,416 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2013-05-21 |
4 |
B |
$3.00 |
$300,000 |
D/D |
100,000 |
268,292 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & CEO |
• • – |
2013-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
30,791 |
157,501 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2011-12-23 |
4 |
B |
$0.50 |
$7,871 |
D/D |
15,902 |
746,516 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2011-12-22 |
4 |
OE |
$0.44 |
$33,000 |
D/D |
75,000 |
730,614 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2011-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
655,614 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President and C.E.O. |
• • – |
2011-09-23 |
4 |
B |
$3.06 |
$3,670 |
D/D |
1,200 |
1,600 |
2.73 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President and C.E.O. |
• • – |
2011-09-23 |
4 |
B |
$0.51 |
$12,171 |
D/D |
24,100 |
608,530 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President and C.E.O. |
• • – |
2011-09-22 |
4 |
B |
$0.59 |
$2,965 |
D/D |
5,000 |
584,430 |
2.73 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2011-09-13 |
4 |
B |
$3.23 |
$1,291 |
D/D |
400 |
400 |
2.73 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2011-09-13 |
4 |
B |
$0.67 |
$8,052 |
D/D |
12,000 |
579,430 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2011-08-22 |
4 |
B |
$0.73 |
$6,721 |
D/D |
9,232 |
567,430 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2010-06-09 |
4 |
OE |
$0.44 |
$33,000 |
D/D |
75,000 |
558,198 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2010-04-23 |
4 |
AS |
$2.50 |
$20,875 |
D/D |
(8,350) |
483,198 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-12-02 |
4 |
B |
$0.37 |
$1,110 |
D/D |
3,000 |
441,548 |
2.73 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-11-20 |
4 |
B |
$0.31 |
$280 |
D/D |
900 |
438,548 |
2.73 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-11-19 |
4 |
B |
$0.36 |
$2,840 |
D/D |
8,000 |
437,648 |
2.73 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-11-18 |
4/A |
B |
$0.47 |
$7,922 |
D/D |
17,000 |
429,648 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-11-18 |
4/A |
A |
$0.00 |
$0 |
D/D |
50,000 |
479,648 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-11-18 |
4 |
S |
$0.47 |
$7,922 |
D/D |
(17,000) |
429,648 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-11-17 |
4 |
S |
$0.50 |
$1,000 |
D/D |
(2,000) |
412,648 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
President & C.E.O. |
• • – |
2008-11-17 |
4/A |
B |
$0.50 |
$1,000 |
D/D |
2,000 |
412,648 |
2.73 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
